Summary
We have compared the toxicologic, pharmacologic, and therapeutic properties of the DNA complexes of daunorubicin and doxorubicin, after intravenous (IV) administration into mice. The overall toxicity of doxorubicin is significantly reduced after IV injection as a DNA complex while daunorubicin-DNA is as toxic as free daunorubicin. On hemopoietic stem cells, daunorubicin-DNA was found to be more cytotoxic than daunorubicin, while the opposite was observed with doxorubicin and doxorubicin-DNA. Both complexes are more effective than the corresponding free drugs on the L 1210 murine leukemia, when given IV at equitoxic doses. The tissue uptake in mice, after IV administration, is generally lower when the drugs are given bound to DNA. The stability of the two DNA complexes is very different in the bloodstream: daunorubicin-DNA behaves more like a prodrug of daunorubicin, while doxorubicin-DNA, remaining stable in the bloodstream, meets much more the requirements of an ideal drugmacromoleculare carrier entity.
Similar content being viewed by others
References
Baurain, R., Deprez-De-Campeneere D., Trouet, A.: Determination of daunorubicin, doxorubicin, and their fluorescent metabolites by high-pressure liquid chromatography: Plasma levels in DBA2 mice. Cancer Chemother. Pharmacol. 2, 11–14 (1979)
Baurain, R., Masquelier, M., Peterson, C., Deprez-De Campeneere, D., Trouet, A.: Quantitative determination of intracellular concentrations of daunorubicin and adriamycin and their main metabolites by high-pressure liquid chromatography. In: Current chemotherapy. Proc. 10th Int. Congr. Chemother., Vol. 2, p. 1130. Siegenthaler, W., Lüthy, R. (eds.). Microbiol. Washington: Am. Soc. 1978
Commerford, S. L.: Iodination of nucleic acids in vitro. Biochemistry 10, 1993 (1971)
Lowry, O. H., Rosebrough, N. J., Farr, A. L. Randall, R. J.: Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265 (1951)
Mancini, G., Carbonara, A. O., Heremans, J. F.: Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry 2, 235 (1965)
Orosz, J. M., Wetmur, J. G.: In vitro iodination of DNA. Maximizing iodination while minimizing degradation. Use of buoyant density shifts for DNA-DNA hybrid isolation. Biochemistry 13, 5467 (1974)
Quesenberry P., Niskanen, E., Symann, M., Howard, D., Ryan, M., Halperin, J., Stohlman, F., Jr.,: Growth of stem cell concentrates in diffusion chambers. Cell Tissue Kinet. 7, 337 (1974)
Till, J. E., McCulloch, E. A.: A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat. Res. 14, 213 (1961)
Trouet, A., Deprez-De Campeneere, D., De Duve, C.: Chemotherapy through lysosomes with a DNA-daunorubicin complex. Nature [New Biol.] 239, 110 (1972)
Trouet, A., Deprez-De Campeneere, D., De Smedt-Malengreaux, M., Atassi, G.: Experimental leukemia chemotherapy with a ‘lysosomotropic’ adriamycin-DNA complex. Eur. J. Cancer 10, 405 (1974)
Valeriote, F. A., Tolen, S. T.: Survival of hematopoietic and lymphoma colony forming cells in vivo following the administration of a variety of alkylating agents. Cancer Res. 32, 470 (1972)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Deprez-De Campeneere, D., Baurain, R., Huybrechts, M. et al. Comparative study in mice of the toxicity, pharmacology, and therapeutic activity of daunorubicin-DNA and doxorubicin-DNA complexes. Cancer Chemother. Pharmacol. 2, 25–30 (1979). https://doi.org/10.1007/BF00253101
Issue Date:
DOI: https://doi.org/10.1007/BF00253101